1457PDEfficacy evaluation of concurrent nivolumab addition...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1457PDEfficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial

Peters, S, Felip, E, Dafni, U, Tufman, A, Guckenberger, M, Irigoyen, A, Nadal, E, Becker, A, Vees, H, Pless, M, Martinez-Marti, A, Lambrecht, M, Andratschke, N, Tsourti, Z, Piguet, A-C, Roschitzki-Vos
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz259
Date:
October, 2019
File:
PDF, 91 KB
2019
Conversion to is in progress
Conversion to is failed